Characterization of monocarboxylate transporter activity in hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 20, Issue 33, 2014, Pages 11780-11787

  Alves, Venâncio A ^a   Pinheiro, Céline ^b,c,d,e   Morais Santos, Filipa ^b,c   Felipe Silva, Aloisio ^a   Longatto Filho, Adhemar ^a,b,c,f   Baltazar, Fátima ^b,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF MINHO   (Portugal)

^c UNIVERSITY OF MINHO   (Portugal)

^d Dr Paulo Prata FACISB   (Brazil)

^e BARRETOS CANCER HOSPITAL   (Brazil)

^f Pio XII Foundation   (Brazil)

Author keywords

Cirrhosis; Glucose transporter 1; Glycolysis; Hepatocellular carcinoma; Monocarboxylate transporters

Indexed keywords

CD147 ANTIGEN; GLUCOSE TRANSPORTER 1; KI 67 ANTIGEN; MONOCARBOXYLATE TRANSPORTER 1; MONOCARBOXYLATE TRANSPORTER 2; MONOCARBOXYLATE TRANSPORTER 4; BSG PROTEIN, HUMAN; COTRANSPORTER; MONOCARBOXYLATE TRANSPORT PROTEIN 1; MONOCARBOXYLATE TRANSPORTER; MUSCLE PROTEIN; SLC16A4 PROTEIN, HUMAN; SLC16A7 PROTEIN, HUMAN; SLC2A1 PROTEIN, HUMAN;

ABDOMINAL CANCER; ARTICLE; AUTOPSY; CELL MEMBRANE; CONTROLLED STUDY; DISEASE ASSOCIATION; GLYCOLYSIS; HEPATITIS B; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER WEIGHT; METASTASIS; PRIMARY TUMOR; PROTEIN EXPRESSION; PROTEIN FUNCTION; BRAZIL; CHEMISTRY; CHI SQUARE DISTRIBUTION; DISEASE COURSE; LIVER; LIVER TUMOR; METABOLISM; PATHOLOGY; PROGNOSIS; SECONDARY;

ANTIGENS, CD147; AUTOPSY; BRAZIL; CARCINOMA, HEPATOCELLULAR; CELL MEMBRANE; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MONOCARBOXYLIC ACID TRANSPORTERS; MUSCLE PROTEINS; PROGNOSIS; SYMPORTERS;

EID: 84909595140     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i33.11780     Document Type: Article

References (30)

1. Jungermann K , Kietzmann T. Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology 2000; 31: 255-260 [PMID: 10655244]
2. Nath B , Szabo G. Hypoxia and hypoxia inducible factors: diverse roles in liver diseases. Hepatology 2012; 55: 622-633 [PMID: 22120903 DOI: 10.1002/hep.25497]
3. Pinheiro C , Longatto-Filho A, Azevedo-Silva J, Casal M, Schmitt FC, Baltazar F. Role of monocarboxylate transporters in human cancers: state of the art. J Bioenerg Biomembr 2012; 44: 127-139 [PMID: 22407107 DOI: 10.1007/s10863-012-9428-1]
4. Warburg O. On the origin of cancer cells. Science 1956; 123: 309-314 [PMID: 13298683]
5. Miranda-Gonc¸alves V, Honavar M, Pinheiro C, Martinho O, Pires MM, Pinheiro C, Cordeiro M, Bebiano G, Costa P, Palmeirim I, Reis RM, Baltazar F. Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets. Neuro Oncol 2013; 15: 172-188 [PMID: 23258846 DOI: 10.1093/neuonc/nos298]
6. Pinheiro C , Longatto-Filho A, Scapulatempo C, Ferreira L, Martins S, Pellerin L, Rodrigues M, Alves VA, Schmitt F, Baltazar F. Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Virchows Arch 2008; 452: 139-146 [PMID: 18188595 DOI: 10.1007/s00428-007-0558-5]
7. Pinheiro C , Longatto-Filho A, Ferreira L, Pereira SM, Etlinger D, Moreira MA, Jubé LF, Queiroz GS, Schmitt F, Baltazar F. Increasing expression of monocarboxylate transporters 1 and 4 along progression to invasive cervical carcinoma. Int J Gynecol Pathol 2008; 27: 568-574 [PMID: 18753962 DOI: 10.1097/PGP.0b013e31817b5b40]
8. Pinheiro C , Longatto-Filho A, Pereira SM, Etlinger D, Moreira MA, Jubé LF, Queiroz GS, Schmitt F, Baltazar F. Monocarboxylate transporters 1 and 4 are associated with CD147 in cervical carcinoma. Dis Markers 2009; 26: 97-103 [PMID: 19597291 DOI: 10.3233/DMA-2009-0596]
9. Pinheiro C, Albergaria A, Paredes J, Sousa B, Dufloth R, Vieira D, Schmitt F, Baltazar F. Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma. Histopathology 2010; 56: 860-867 [PMID: 20636790 DOI: 10.1111/j.1365-2559.2010.03560.x]
10. Pinheiro C, Longatto-Filho A, Simões K, Jacob CE, Bresciani CJ, Zilberstein B, Cecconello I, Alves VA, Schmitt F, Baltazar F. The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer. Eur J Cancer 2009; 45: 2418-2424 [PMID: 19628385 DOI: 10.1016/j.ejca.2009.06.018]
11. Pértega-Gomes N , Vizcaíno JR, Miranda-Gonc¸alves V, Pinheiro C, Silva J, Pereira H, Monteiro P, Henrique RM, Reis RM, Lopes C, Baltazar F. Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer. BMC Cancer 2011; 11: 312 [PMID: 21787388 DOI: 10.1186/1471-2407-11-312]
12. Pinheiro C, Sousa B, Albergaria A, Paredes J, Dufloth R, Vieira D, Schmitt F, Baltazar F. GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression. Histol Histopathol 2011; 26: 1279-1286 [PMID: 21870331]
13. Mathupala SP , Parajuli P, Sloan AE. Silencing of monocarboxylate transporters via small interfering ribonucleic acid inhibits glycolysis and induces cell death in malignant glioma: an in vitro study. Neurosurgery 2004; 55: 1410-1419; discussion 1419 [PMID: 15574223]
14. Pinheiro C, Longatto-Filho A, Soares TR, Pereira H, Bedrossian C, Michael C, Schmitt FC, Baltazar F. CD147 immunohistochemistry discriminates between reactive mesothelial cells and malignant mesothelioma. Diagn Cytopathol 2012; 40: 478-483 [PMID: 22619123 DOI: 10.1002/dc.22821]
15. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917 [PMID: 21351269 DOI: 10.1002/ijc.25516]
16. Montalto G, Cervello M, Giannitrapani L, Dantona F, Terranova A, Castagnetta LA. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann N Y Acad Sci 2002; 963: 13-20 [PMID: 12095924]
17. Felipe da Silva AS. Expression analysis of EGFR and related proteins in hepatocellular carcinoma and surrounding liver tissue metastases: clinicopathologic study in autopsies. Brazil: PhD Thesis, Faculdade de Medicina da Universidade de São Paulo, 2013
18. Hoshida Y, Toffanin S, Lachenmayer A, Villanueva A, Minguez B, Llovet JM. Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin Liver Dis 2010; 30: 35-51 [PMID: 20175032 DOI: 10.1055/s-0030-1247131]
19. Rüschoff J, Kerr KM, Grote HJ, Middel P, von Heydebreck A, Alves VA, Baldus SE, Büttner R, Carvalho L, Fink L, Jochum W, Lo AW, López-Ríos F, Marx A, Molina TJ, Olszewski WT, Rieker RJ, Volante M, Thunnissen E, Wrba F, Celik I, Störkel S. Reproducibility of immunohistochemical scoring for epidermal growth factor receptor expression in non-small cell lung cancer: round robin test. Arch Pathol Lab Med 2013; 137: 1255-1261 [PMID: 23270410 DOI: 10.5858/arpa.2012-0605-OA]
20. Pinheiro C, Reis RM, Ricardo S, Longatto-Filho A, Schmitt F, Baltazar F. Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44. J Biomed Biotechnol 2010; 2010: 427694 [PMID: 20454640 DOI: 10.1155/2010/427694]
21. de Oliveira AT , Pinheiro C, Longatto-Filho A, Brito MJ, Martinho O, Matos D, Carvalho AL, Vazquez VL, Silva TB, Scapulatempo C, Saad SS, Reis RM, Baltazar F. Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs). J Bioenerg Biomembr 2012; 44: 171-178 [PMID: 22281667 DOI: 10.1007/s10863-012-9408-5]
22. Sonveaux P , Végran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, De Saedeleer CJ, Kennedy KM, Diepart C, Jordan BF, Kelley MJ, Gallez B, Wahl ML, Feron O, Dewhirst MW. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 2008; 118: 3930-3942 [PMID: 19033663 DOI: 10.1172/JCI36843]
23. Pinheiro C, Longatto-Filho A, Nogueira R, Schmitt F, Baltazar F. Lactate-induced IL-8 pathway in endothelial cells - letter. Cancer Res 2012; 72: 1901-1902; author reply 1903-1904 [PMID: 22473315 DOI: 10.1158/0008-5472]
24. Roncalli M , Park YN, Di Tommaso L. Histopathological classification of hepatocellular carcinoma. Dig Liver Dis 2010; 42 Suppl 3: S228-S234 [PMID: 20547308 DOI: 10.1016/S1590-8658(10)60510-5]
25. Halestrap AP, Wilson MC. The monocarboxylate transporter family - role and regulation. IUBMB Life 2012; 64: 109-119 [PMID: 22162139 DOI: 10.1002/iub.572]
26. Arzumanyan A, Reis HM, Feitelson MA. Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat Rev Cancer 2013; 13: 123-135 [PMID: 23344543 DOI: 10.1038/nrc3449]
27. Ripoli M, D'Aprile A, Quarato G, Sarasin-Filipowicz M, Gouttenoire J, Scrima R, Cela O, Boffoli D, Heim MH, Moradpour D, Capitanio N, Piccoli C. Hepatitis C virus-linked mitochondrial dysfunction promotes hypoxia-inducible factor 1 alpha-mediated glycolytic adaptation. J Virol 2010; 84: 647-660 [PMID: 19846525 DOI: 10.1128/JVI.00769-09]
28. Airley RE , Mobasheri A. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy 2007; 53: 233-256 [PMID: 17595539]
29. Amann T, Maegdefrau U, Hartmann A, Agaimy A, Marienhagen J, Weiss TS, Stoeltzing O, Warnecke C, Schölmerich J, Oefner PJ, Kreutz M, Bosserhoff AK, Hellerbrand C. GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. Am J Pathol 2009; 174: 1544-1552 [PMID: 19286567 DOI: 10.2353/ajpath.2009.080596]
30. Benton CR, Campbell SE, Tonouchi M, Hatta H, Bonen A. Monocarboxylate transporters in subsarcolemmal and intermyofibrillar mitochondria. Biochem Biophys Res Commun 2004; 323: 249-253 [PMID: 15351729]